Flukiver 5% w/v Oral Suspension

البلد: المملكة المتحدة

اللغة: الإنجليزية

المصدر: VMD (Veterinary Medicines Directorate)

اشتر الآن

خصائص المنتج خصائص المنتج (SPC)
05-09-2023

العنصر النشط:

Closantel

متاح من:

Elanco Europe Ltd

ATC رمز:

QP52AG09

INN (الاسم الدولي):

Closantel

الشكل الصيدلاني:

Oral suspension

نوع الوصفة الطبية :

POM-VPS -Prescription Only Medicine – Veterinarian, Pharmacist, Suitably Qualified Person

المجموعة العلاجية:

Sheep

المجال العلاجي:

Anthelmintic flukicide

الوضع إذن:

Authorized

تاريخ الترخيص:

1986-12-01

خصائص المنتج

                                Revised: October 2020
AN: 00844/2020
Page 1 of 5
SUMMARY OF PRODUCT CHARACTERISTICS
1.
NAME OF THE VETERINARY MEDICINAL PRODUCT
Flukiver 5% w/v Oral Suspension
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
ACTIVE SUBSTANCE:
MG/ML
Closantel
50.00
(as Closantel Sodium Dihydrate
54.375)
For full list of excipients, see section 6.1.
3.
PHARMACEUTICAL FORM
Oral suspension
Off-white to slightly yellow, homogeneous suspension.
4.
CLINICAL PARTICULARS
4.1
TARGET SPECIES
Sheep and lambs
4.2
INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
For the control of chronic and subacute fascioliasis (due to _Fasciola
hepatica_) in sheep and
lambs.
For the control of _Oestrus ovis_ (Sheep Nasal Bot Fly)_._
For the control of inhibited, immature and adult stages of _Haemonchus
contortus_ (Barber
Pole Worm) including benzimidazole resistant strains.
Flukiver is active against mature and immature flukes.
_Fluke activity:_
_Stage_
_Percentage kill_
Adults
97-100 %
6-8 weeks immature
91-95%
5 weeks immature
91%
3-4 weeks immature
23-73 %
Ticks (_Ixodes ricinus_) feeding on sheep at the time of treatment are
likely to produce fewer
viable eggs.
Revised: October 2020
AN: 00844/2020
Page 2 of 5
4.3
CONTRAINDICATIONS
None
4.4
SPECIAL WARNINGS FOR TARGET SPECIES
Care should be taken to avoid the following practices because they
increase the risk of
development of resistance and could ultimately result in ineffective
therapy:
•
Too frequent and repeated use of anthelmintics from the same class,
over an
extended period of time.
•
Underdosing,
which
may
be
due
to
underestimation
of
body
weight,
misadministration of the product, or lack of calibration of the dosing
device (if any).
Suspected clinical cases of resistance to anthelmintics should be
further investigated
using appropriate tests (e.g. Faecal Egg Count Reduction Test). Where
the results of the
test(s) strongly suggest resistance to a particular anthelmintic, an
anthelmintic belonging
to another pharmacological class and having a different mode of action
should be used.
Resistance 
                                
                                اقرأ الوثيقة كاملة
                                
                            

تنبيهات البحث المتعلقة بهذا المنتج

عرض محفوظات المستندات